Reinhard Karge, an internationally renowned expert in pharmaceutical and chemical engineering, has been appointed as a Distinguished Professor at JXNU.

Time:2025-09-29From:江西师范大学英文网

On the afternoon of September 26th, the university held a signing ceremony for the appointment of a Distinguished Professor and a presentation ceremony for the appointment letter, engaging Reinhard Karge, the founder and president of RCJ unlimited - Karge consulting (Karge Consulting), as a Distinguished Professor for the School of Chemistry and Materials Science. Academician Chen Fen'er, the university president, along with Liu Limin, a member of the Party Committee Standing Committee and vice president of the university, attended the appointment ceremony. Leaders from relevant schools and departments of the university also participated.

Chen Fen'er presented the appointment letter to Professor Reinhard Karge and, on behalf of the university, extended a warm welcome to his joining Jiangxi Normal University. She expressed anticipation that Professor Reinhard Karge would leverage his extensive resources in the international pharmaceutical and fine chemical industries to help the university enhance the efficiency of transforming scientific research achievements, effectively promote the deep integration of the university's talent chain, innovation chain, discipline chain, and industrial chain, strengthen the university's international influence, and provide stronger support for local economic and social development as well as industry advancement.


Professor Reinhard Karge expressed gratitude for the university's trust and stated that he would fulfill his responsibilities diligently, deeply participate in the university's discipline construction, precisely align with the actual needs of the industry, and contribute to enhancing the university's internationalization level and scientific and technological innovation capabilities.



It is reported that Professor Reinhard Karge is an internationally renowned expert in pharmaceuticals and fine chemicals with 40 years of experience. He specializes in active pharmaceutical ingredient (API) process development, Good Manufacturing Practice (GMP)-compliant production, and global outsourcing management. Combining cutting-edge academic insights with practical industrial experience, he has achieved remarkable accomplishments in the fields of vitamin synthesis, biocatalysis, and the industrialization of innovative drugs. His career trajectory spans the entire spectrum of research and development, production, and commercialization, making him a key driver in bridging scientific innovation with industrial scalability.